Used in research settings as a selective serotonin receptor agonist, particularly targeting 5-HT1F receptors, to study migraine pathways and evaluate potential anti-migraine therapies. Shows promise in preclinical models for treating acute migraine without causing vasoconstriction, making it a candidate for further development in neurology and pain management. Also utilized to investigate the role of serotonin signaling in central nervous system disorders.